NASDAQ NMS - GLOBAL MARKET · ABSI
-9.93% · -$1.02 · Vol 5.9M
Market closed · last close 4:00 PM ET · price as of 19:56:39 ET
Absci Corp

Absci Corp

Biotechnology
$9.25
Card
Relationship Map

Follow $ABSI

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $ABSI by email

Veridion Score

BETALOW CONF · 6 of 6 factors measuredMethodology
ABSI
Absci Corp
Wed Oct 7 · last completed session · Markets closed · resumes Thu 9:30 ET
Lower range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

44/ 100
Veridion Score
Lower range · LOW confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 6 of 6 factors measured · Wed Oct 7 · last completed session · Markets closed · resumes Thu 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is ABSI moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading ABSI catalysts
About Absci Corp
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Listed since
2021
Employees
140
Country
US

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$10.00
Day high
$10.22
Day low
$9.12
Previous close
$10.27
52W high
$11.62
-20.40% from high
52W low
$2.30
75% of range
Market cap
$1.8B
EPS
$-0.8002
Beta
3.45
Shares out
171.6M
Volume
5.9M
1.47× rel vol
Avg volume
4M
VWAP
$9.44
Price history computed in-house
1W
-13.95%
1M
+3.82%
3M
-12.73%
1Y
+121.29%
YTD
+165.05%
SMA 50 $9.17 · above
SMA 200 $5.97 · above
52W position 75%

ABSI overview

Veridion Score
44
Registered · 2026-10-07
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around ABSI.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading ABSI Form 4 filings
Public disclosures

Congress activity in ABSI

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified filings found.

Federal contracts

ABSI contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ABSI in this window.
Lobbying spend

ABSI lobbying filings, year to date.

Registered lobbying filings matched to Absci Corp.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ABSI in this window.
Loading news for ABSI
Analyst ratings
Sovereign unlock shows live analyst consensus for ABSI.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.